Bharat Parenterals Q3 FY24 Results Live: Profit Rises by 32.98% YoY
Bharat Parenterals declared their Q3 FY24 results on 13 Feb, 2024. The topline increased by 1.36% & the profit increased by 32.98% YoY. As compared to the previous quarter, the revenue grew by 0.02% and the profit increased by 7.67%.
The Selling, general & administrative expenses declined by 9.39% q-o-q & increased by 17.74% Y-o-Y.
The operating income was up by 86.38% q-o-q & increased by 295.87% Y-o-Y.
The EPS is ₹6.45 for Q3 FY24 which increased by 30.57% Y-o-Y.
Bharat Parenterals has delivered 9.98% return in the last 1 week, 42.72% return in the last 6 months, and 11.37% YTD return.
Currently, Bharat Parenterals has a market cap of ₹525.05 Cr and a 52wk high/low of ₹975 & ₹315.05 respectively.
| Period | Q3 FY24 | Q2 FY24 | Q-o-Q Growth | Q3 FY23 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 59.82 | 59.81 | +0.02% | 59.02 | +1.36% |
| Selling/ General/ Admin Expenses Total | 5.31 | 5.86 | -9.39% | 4.51 | +17.74% |
| Depreciation/ Amortization | 1.82 | 1.75 | +4% | 1.44 | +26.39% |
| Total Operating Expense | 55.03 | 57.24 | -3.86% | 57.81 | -4.81% |
| Operating Income | 4.79 | 2.57 | +86.38% | 1.21 | +295.87% |
| Net Income Before Taxes | 5.47 | 4.54 | +20.48% | 3.9 | +40.26% |
| Net Income | 3.79 | 3.52 | +7.67% | 2.85 | +32.98% |
| Diluted Normalized EPS | 6.45 | 6.07 | +6.26% | 4.94 | +30.57% |
FAQs
Question : What is the Q3 FY24 profit/Loss as per company?
Ans : ₹3.79Cr
Question : What is Q3 FY24 revenue?
Ans : ₹59.82Cr
Stay updated on quarterly results with our results calendar
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it’s all here, just a click away! Login Now!
Download Finplay News App to get Daily Market Updates & Live Business News.
More
Less
Published: 15 Feb 2024, 02:08 AM IST
Ganesh
http://ganesh@finplay.inFinance enthusiast, Mutual fund expert.